Snapshot from Jul 31, 2026 at 07:00 UTC. For live data and tracking: View Live
Events / Regulatory / GRAIL Securities Class Action Lawsuit
Regulatory Securities Fraud

GRAIL Securities Class Action Lawsuit

Analysis based on 315 articles · First reported Jun 05, 2026 · Last updated Jul 14, 2026

Sentiment
-60
Attention
4
Articles
315
Market Impact
General
Live prominence charts, article sentiment distribution, and event development timeline available on the Ergen Dashboard
Market Impact

The failed trial and subsequent stock drop have severely damaged investor confidence in Illumina — Holy Grail, leading to a significant loss of market value. The securities class action may result in substantial financial penalties and reputational harm for the company, potentially affecting its ability to raise capital and continue operations.

Healthcare Biotechnology
Event Summary

A securities class action lawsuit has been filed against Illumina — Holy Grail, Inc. (NASDAQ: GRAL) and certain of its officers, alleging violations of federal securities laws. The lawsuit claims that Illumina — Holy Grail made materially false and misleading statements regarding its NHS-Galleri trial, which aimed to demonstrate a statistically significant reduction in Stage III-IV cancers. On February 19, 2026, Illumina — Holy Grail announced that the trial failed to meet its primary endpoint, attributing the failure to an insufficient three-year follow-up period. This disclosure caused Illumina — Holy Grail's stock price to drop over 50%, wiping out approximately $2.2 billion in market capitalization. Multiple law firms, including Bronstein, Gewirtz & Grossman, LLC, Pomerantz LLP, Rosen Law Firm, The Schall Law Firm, Hagens Berman, Berger Montague, Bleichmar Fonti & Auld LLP, Bernstein Liebhard LLP, Faruqi & Faruqi, Glancy Prongay & Murray, and Robbins Geller Rudman & Dowd LLP, have announced the filing of the class action and are urging investors to join. The lead plaintiff deadline is August 4, 2026.

Key Actions
99 Illumina — Holy Grail announced trial endpoint not observed
90 Bronstein, Gewirtz & Grossman, LLC filed class action lawsuit Holy Grail
90 Robbins Geller Rudman & Dowd LLP filed class action lawsuit Holy Grail
90 Robbins Geller Rudman & Dowd LLP filed class action lawsuit Illumina — Holy Grail
90 The Law Offices of Frank R. Cruz filed class action lawsuit Illumina — Holy Grail
88 Pomerantz LLP filed class action lawsuit Illumina — Holy Grail
85 Bronstein, Gewirtz & Grossman, LLC filed class action lawsuit Illumina — Holy Grail
82 Rosen Law Firm announced class action lawsuit Illumina — Holy Grail
82 The Schall Law Firm filed class action lawsuit Illumina — Holy Grail
81 Bleichmar Fonti & Auld LLP filed lawsuit Illumina — Holy Grail
80 The Schall Law Firm reminded investors of lawsuit Illumina — Holy Grail
80 Berger Montague filed class action lawsuit Illumina — Holy Grail
77 Hagens Berman filed class action Illumina — Holy Grail
72 Glancy Prongay & Murray filed lawsuit Illumina — Holy Grail
70 Faruqi & Faruqi filed class action lawsuit Illumina — Holy Grail
+ 2 more actions View on Dashboard
Entities Involved
oth
Holy Grail
Holy Grail>>> is the defendant in multiple class action lawsuits due to alleged misleading statements regarding its NHS-Galleri trial results, leading to a significant stock price drop.
Importance 100.0 Sentiment -90.0
subs
Illumina — Holy Grail
Illumina — Holy Grail is the defendant in the securities class action; its stock dropped over 50% after the NHS-Galleri trial failed to meet its primary endpoint, resulting in a $2.2 billion market cap loss.
Importance 100.0 Sentiment -80.0
priv
Robbins LLP
Robbins LLP is a law firm that informs stockholders about a class action filed against Illumina — Holy Grail, Inc. for allegedly misleading investors.
Importance 60.0 Sentiment 50.0
per
Aaron Dumas, Jr.
Aaron Dumas, Jr. is an attorney at Robbins LLP, providing information to stockholders about the class action against Illumina — Holy Grail, Inc.
Importance 30.0 Sentiment 50.0
per
James Wilson
James Wilson is a partner at Faruqi & Faruqi, encouraging investors to contact him regarding losses in Illumina — Holy Grail.
Importance 30.0 Sentiment 50.0
cnt
United Kingdom
The United Kingdom's United Kingdom — National Health Service (NHS) was involved in the NHS-Galleri trial, which is central to the class action lawsuits against Illumina — Holy Grail, Inc.
Importance 30.0 Sentiment 0.0
per
Ken Dolitsky
Ken Dolitsky is an attorney at Robbins Geller Rudman & Dowd LLP, providing contact information for investors interested in the Illumina — Holy Grail class action lawsuit.
Importance 30.0 Sentiment 50.0
per
Michael Albert
Michael Albert is an attorney at Robbins Geller Rudman & Dowd LLP, providing contact information for investors interested in the Illumina — Holy Grail class action lawsuit.
Importance 30.0 Sentiment 50.0
priv
The Law Offices of Frank R. Cruz
Filed a class action lawsuit against Illumina — Holy Grail on behalf of investors.
Importance 30.0 Sentiment 0.0
priv
Bronstein, Gewirtz & Grossman, LLC
Bronstein, Gewirtz & Grossman, LLC is one of the law firms that filed the class action lawsuit against Illumina — Holy Grail, representing investors.
Importance 30.0 Sentiment 0.0
priv
Rosen Law Firm
Rosen Law Firm is one of the law firms that filed the class action lawsuit against Illumina — Holy Grail, representing investors.
Importance 30.0 Sentiment 0.0
priv
Pomerantz LLP
Pomerantz LLP is one of the law firms that filed the class action lawsuit against Illumina — Holy Grail, representing investors.
Importance 30.0 Sentiment 0.0
govactor
United Kingdom — National Health Service
The NHS conducted the Galleri trial in the UK; the trial's failure may affect future collaboration with Illumina — Holy Grail.
Importance 30.0 Sentiment 0.0
per
Josh Wilson
Josh Wilson is a partner at Faruqi & Faruqi, encouraging investors who suffered losses in Illumina — Holy Grail to contact him directly to discuss their legal options.
Importance 20.0 Sentiment 40.0
priv
Bleichmar Fonti & Auld LLP
Bleichmar Fonti & Auld LLP is one of the law firms that filed the class action lawsuit against Illumina — Holy Grail, representing investors.
Importance 20.0 Sentiment 0.0
+ 23 more entities View on Dashboard
Relationships
Illumina — Holy Grail related ↔ The Law Offices of Frank R. Cruz
Illumina — Holy Grail related ↔ Bronstein, Gewirtz & Grossman, LLC
Robbins LLP related ↔ Aaron Dumas, Jr.
Robbins LLP related ↔ James Wilson
Robbins LLP related ↔ Ken Dolitsky
Robbins LLP related ↔ Michael Albert
Robbins LLP related ↔ The Law Offices of Frank R. Cruz
Robbins LLP co-counsel ↔ Bronstein, Gewirtz & Grossman, LLC Robbins LLP frequently serves as co-counsel with Bronstein, Gewirtz & Grossman, LLC in numerous securities class action
Aaron Dumas, Jr. related ↔ James Wilson
Aaron Dumas, Jr. related ↔ Ken Dolitsky
Aaron Dumas, Jr. related ↔ Michael Albert
Aaron Dumas, Jr. related ↔ The Law Offices of Frank R. Cruz
Aaron Dumas, Jr. related ↔ Bronstein, Gewirtz & Grossman, LLC
James Wilson related ↔ Ken Dolitsky
James Wilson related ↔ Michael Albert
+ 8 more relationships View on Dashboard
ERGEN INTELLIGENCE
Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.